Cargando…
Immune disorders and rheumatologic manifestations of viral hepatitis
Infection with hepatotropic viruses is not limited to the liver and can lead to the development of various immunological disorders (the formation of cryoglobulins, rheumatoid factor, antinuclear antibodies, autoantibodies specific for autoimmune hepatitis and primary biliary cholangitis, and others)...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117740/ https://www.ncbi.nlm.nih.gov/pubmed/34025065 http://dx.doi.org/10.3748/wjg.v27.i18.2073 |
_version_ | 1783691636559052800 |
---|---|
author | Maslennikov, Roman Ivashkin, Vladimir Efremova, Irina Shirokova, Elena |
author_facet | Maslennikov, Roman Ivashkin, Vladimir Efremova, Irina Shirokova, Elena |
author_sort | Maslennikov, Roman |
collection | PubMed |
description | Infection with hepatotropic viruses is not limited to the liver and can lead to the development of various immunological disorders (the formation of cryoglobulins, rheumatoid factor, antinuclear antibodies, autoantibodies specific for autoimmune hepatitis and primary biliary cholangitis, and others), which can manifest as glomerulonephritis, arthritis, uveitis, vasculitis (cryoglobulinemic vasculitis, polyarteritis nodosa, Henoch-Schonlein purpura, isolated cutaneous necrotizing vasculitis), and other rheumatologic disorders, and be a trigger for the subsequent development of autoimmune hepatitis and primary biliary cholangitis. A further study of the association between autoimmune liver diseases and hepatotropic virus infection would be useful to assess the results of treatment of these associated diseases with antiviral drugs. The relationship of these immune disorders and their manifestations with hepatotropic viruses is best studied for chronic hepatitis B and C. Only isolated cases of these associations are described for hepatitis A. These links are least studied, and are often controversial for hepatitis E, possibly due to their relatively rare diagnoses. Patients with uveitis, glomerulonephritis, arthritis, vasculitis, autoimmune liver diseases should be tested for biomarkers of viral hepatitis, and if present, these patients should be treated with antiviral drugs. |
format | Online Article Text |
id | pubmed-8117740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-81177402021-05-20 Immune disorders and rheumatologic manifestations of viral hepatitis Maslennikov, Roman Ivashkin, Vladimir Efremova, Irina Shirokova, Elena World J Gastroenterol Review Infection with hepatotropic viruses is not limited to the liver and can lead to the development of various immunological disorders (the formation of cryoglobulins, rheumatoid factor, antinuclear antibodies, autoantibodies specific for autoimmune hepatitis and primary biliary cholangitis, and others), which can manifest as glomerulonephritis, arthritis, uveitis, vasculitis (cryoglobulinemic vasculitis, polyarteritis nodosa, Henoch-Schonlein purpura, isolated cutaneous necrotizing vasculitis), and other rheumatologic disorders, and be a trigger for the subsequent development of autoimmune hepatitis and primary biliary cholangitis. A further study of the association between autoimmune liver diseases and hepatotropic virus infection would be useful to assess the results of treatment of these associated diseases with antiviral drugs. The relationship of these immune disorders and their manifestations with hepatotropic viruses is best studied for chronic hepatitis B and C. Only isolated cases of these associations are described for hepatitis A. These links are least studied, and are often controversial for hepatitis E, possibly due to their relatively rare diagnoses. Patients with uveitis, glomerulonephritis, arthritis, vasculitis, autoimmune liver diseases should be tested for biomarkers of viral hepatitis, and if present, these patients should be treated with antiviral drugs. Baishideng Publishing Group Inc 2021-05-14 2021-05-14 /pmc/articles/PMC8117740/ /pubmed/34025065 http://dx.doi.org/10.3748/wjg.v27.i18.2073 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Review Maslennikov, Roman Ivashkin, Vladimir Efremova, Irina Shirokova, Elena Immune disorders and rheumatologic manifestations of viral hepatitis |
title | Immune disorders and rheumatologic manifestations of viral hepatitis |
title_full | Immune disorders and rheumatologic manifestations of viral hepatitis |
title_fullStr | Immune disorders and rheumatologic manifestations of viral hepatitis |
title_full_unstemmed | Immune disorders and rheumatologic manifestations of viral hepatitis |
title_short | Immune disorders and rheumatologic manifestations of viral hepatitis |
title_sort | immune disorders and rheumatologic manifestations of viral hepatitis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117740/ https://www.ncbi.nlm.nih.gov/pubmed/34025065 http://dx.doi.org/10.3748/wjg.v27.i18.2073 |
work_keys_str_mv | AT maslennikovroman immunedisordersandrheumatologicmanifestationsofviralhepatitis AT ivashkinvladimir immunedisordersandrheumatologicmanifestationsofviralhepatitis AT efremovairina immunedisordersandrheumatologicmanifestationsofviralhepatitis AT shirokovaelena immunedisordersandrheumatologicmanifestationsofviralhepatitis |